United States · Health Care · USD (Thousands) · Annual
Reported figures and Equlion model projections for the next 5 years.
Sector average (own scale)
Amounts in USD (thousands); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for ProtoKinetix, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.
| Key metrics | Actual | Forecast | ||||
|---|---|---|---|---|---|---|
| Metric | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
| ROE | -123.01% | -389.31% | 134.57% | 57.37% | 36.45% | 26.72% |
|---|---|---|---|---|---|---|
| Sector average | 20.42% | 71.17% | 5.82% | 58.79% | 17.46% | 2.74% |
| ROA | -82.92% | -86.6% | -92.45% | -92.45% | -92.45% | -92.45% |
| Total Assets | $483.37K | $425.80K | $425.80K | $425.80K | $425.80K | $425.80K |
| Net Income | -$393.65K | -$393.65K | -$393.65K | -$393.65K | -$393.65K | -$393.65K |